Mainz Biomed B.V. (MYNZ)
NASDAQ: MYNZ · IEX Real-Time Price · USD
0.890
-0.014 (-1.57%)
At close: Apr 19, 2024, 3:58 PM
0.905
+0.015 (1.69%)
After-hours: Apr 19, 2024, 4:00 PM EDT
Mainz Biomed B.V. Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Mainz Biomed B.V. stock has a target of 3.00, which predicts an increase of 237.08% from the current stock price of 0.89.
Analyst Consensus: Buy
* Price targets were last updated on Mar 6, 2024.
Analyst Ratings
The average analyst rating for MYNZ stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +237.08% | Mar 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 21, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $5 | Strong Buy | Maintains | $9 → $5 | +461.80% | Nov 20, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $9 | Buy | Reiterates | $9 | +911.24% | Sep 26, 2023 |
Financial Forecast
Revenue This Year
2.64M
from 895.48K
Increased by 194.59%
Revenue Next Year
7.68M
from 2.64M
Increased by 191.28%
EPS This Year
-0.83
from -1.62
EPS Next Year
-0.80
from -0.83
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.7M | 8.3M | 15.9M |
| Avg | 2.6M | 7.7M | 15.4M |
| Low | 1.5M | 7.1M | 14.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 310.4% | 213.1% | 106.3% |
| Avg | 194.6% | 191.3% | 100.4% |
| Low | 64.2% | 167.5% | 92.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.76 | -0.64 | -0.56 |
| Avg | -0.83 | -0.80 | -0.54 |
| Low | -0.86 | -0.93 | -0.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.